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Background: Fanconi anemia (FA) is characterized by sensitivity to DNA cross-linking agents, mild cellular, and
marked clinical radio sensitivity. In this study we investigated telomeric abnormalities of non-immortalized primary
cells (lymphocytes and fibroblasts) derived from FA patients of the FA-D2 complementation group, which provides
a more accurate physiological assessment than is possible with transformed cells or animal models.
Results: We analyzed telomere length, telomere dysfunction-induced foci (TIFs), sister chromatid exchanges (SCE),
telomere sister chromatid exchanges (T-SCE), apoptosis and expression of shelterin components TRF1 and TRF2.
FANCD2 lymphocytes exhibited multiple types of telomeric abnormalities, including premature telomere shortening,
increase in telomeric recombination and aberrant telomeric structures ranging from fragile to long-string extended
telomeres. The baseline incidence of SCE in FANCD2 lymphocytes was reduced when compared to control, but in
response to diepoxybutane (DEB) the 2-fold higher rate of SCE was observed. In contrast, control lymphocytes showed
decreased SCE incidence in response to DEB treatment. FANCD2 fibroblasts revealed a high percentage of TIFs,
decreased expression of TRF1 and invariable expression of TRF2. The percentage of TIFs inversely correlated with
telomere length, emphasizing that telomere shortening is the major reason for the loss of telomere capping function.
Upon irradiation, a significant decrease of TIFs was observed at all recovery times. Surprisingly, a considerable
percentage of TIF positive cells disappeared at the same time when incidence of γ-H2AX foci was maximal. Both
FANCD2 leucocytes and fibroblasts appeared to die spontaneously at higher rate than control. This trend was more
evident upon irradiation; the percentage of leucocytes underwent apoptosis was 2.59- fold higher than that in control,
while fibroblasts exhibited a 2- h delay before entering apoptosis.
Conclusion: The results of our study showed that primary cells originating from FA-D2 patients display shorten
telomeres, elevated incidence of T-SCEs and high frequency of TIFs. Disappearance of TIFs in early response to
irradiation represent distinctive feature of FANCD2 cells that should be examined further.
Keywords: Primary FA cells, Telomere dysfunction, Expression of TRF1 and TRF2Background
Located at the ends of chromosomes, telomeres protect
chromosomal termini from nucleolytic degradation and
erroneous DNA repair; they also prevent activation of
DNA damage checkpoints. Human telomeres consist of
tandem arrays of a short repetitive DNA sequence
(TTAGGG) oriented 5' to 3' towards the chromosome and
ending in a single-stranded G rich 3’ overhang. In human
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reproduction in any medium, provided the orthey vary between individuals (e.g., from 10 to 15 kb in
newborns). Telomere length is maintained by dynamic
lengthening and shortening. Shortening results from
nucleolytic degradation and incomplete DNA replication,
whereas lengthening primarily results from telomerase ac-
tivity, which restores telomeric sequences lost during
DNA replication [1]. Telomeric repeats act as binding sites
for shelterin: a six-subunit protein complex that protects
chromosome ends [2]. Three shelterin subunits, TRF1,
TRF2 and POT1, directly recognize TAAGGG repeats.
TRF1 and TRF2 bind to double-stranded repeats of the
telomere sequence, while POT1 binds single-stranded
sites. TRF1 negatively regulates telomere length [3,4] buttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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TRF2 protects chromosome ends by repressing DNA
damage induced signaling, non-homologous end joining
(NHEJ) and homologous recombination repair (HRR)
[6-8]. Telomere dysfunction occurs via the loss of telo-
mere capping function or critical telomere shortening.
Both mechanisms lead to the recruitment of DNA damage
response (DDR) proteins and formation of telomere
dysfunction-induced foci (TIFs) [9-11]. Defects in several
DDR factors lead to telomere dysfunction in humans and
mice [12]. Fanconi anemia (FA) is characterized by sensi-
tivity to DNA cross-linking agents, mild cellular radio sen-
sitivity and marked clinical radio sensitivity. Dysfunctional
telomeres could account for this mild cellular radio sensi-
tivity as a source of endogenous DNA damage. It is
already known that FA cells show altered telomere main-
tenance [13-16], defects in DDR [17] and significant delay
in repair kinetics of radiation-induced lesions [18]. We
analyzed several telomere maintenance parameters, in-
cluding telomere length, TIFs and recombination frequen-
cies in the whole genome (sister chromatid exchange
(SCE)) as well as at telomeres (telomere sister chromatid
exchange (T-SCE)). In addition, we measured apoptosis
and expression of the shelterin components TRF1 and
TRF2 following exposure to ionizing radiation and the
cross-linking agent diepoxybutane (DEB). The study was
performed using non-immortalized primary cells derived
from FA patients of the FANCD2 complementation group,
providing a more accurate physiological assessment than
is possible with transformed cells or animal models.
Results
Assignment of FA patients to complementation group D2
FA patients were assigned to FA-D2 subtype by im-
munoblotting. The absence of FANCD2 bands on stand-
ard exposure immunoblots suggested that all three
patients (1823, 1866 and 1879) belong to complementa-
tion group FA-D2 (Figure 1). The over-exposure of the
films showed faint FANCD2 bands upon MMC treat-
ment unequivocally indicating that all patients have hypo-
morphic mutations in FANCD2 as previously described
for a larger population of FA-D2 patients [19]. For patient
2093, complementation group analysis was previously per-
formed (Universität Würzburg, Institut für Humangenetik,
Germany) and showed that she also belongs to FA-D2
complementation group.
Telomere length analysis in FANCD2 lymphocytes by
quantitative fluorescence in situ hybridization
Representative examples of metaphase spreads hybri-
dized with telomeric PNA probes using Q-FISH and
CO-FISH protocols are presented in Figure 2. The meas-
urement of telomere length (Figure 3a) revealed that
FA-D2 patients exhibited reduced lymphocyte telomerelength (23.50 ± 8.80), relative to age-matched controls
(40.70± 7.36) (P= 0.024). The distribution of telomere
length (Figure 3b) indicated that, in FANCD2 cells, 5% of
telomeres displayed lengths of 0–10 relative length telo-
mere unit (RTLU), and more than 50% of all telomeres
were only 10–20 RTLU long. In control lymphocytes, the
majority of telomeres were 30–50 RTLU long (62.5%),
short telomeres were not present and 15% of telomeres
displayed lengths of 50–80 RTLU. Control lymphocytes
displayed typical Poisson distributions for individual
chromosome telomere length, whereas the peak of
Poisson distribution was shifted leftward in FANCD2 cells.
The average percentage of cells displaying fragile telo-
meres (18,45%) and long-extended telomeres (17,83%) in
FANCD2 lymphocytes are presented in Figure 3c.
Effects of diepoxybutane on the incidence of sister
chromatid exchange and telomere sister chromatid
exchange in FANCD2 lymphocytes
The incidence of spontaneous SCE in FANCD2 lympho-
cytes (3.87 ± 0.28) was significantly reduced when com-
pared to control (4.89 ± 1.16) (P < 0.05) (Figure 3d). In
response to DEB, a nearly two-fold increase of SCEs was
observed in FANCD2 lymphocytes (6.68 ± 1.85), relative
to the baseline state before treatment (P = 0.04). Appear-
ance of double SCE (dSCE) in response to DEB fre-
quently were observed (Figure 3e). In contrast, the same
concentration of DEB decreased SCEs in control cells
(4.35 ± 1.27) (P = 0.034).
CO-FISH indicated that the incidence of spontan-
eously occurring T-SCEs in FANCD2 primary lympho-
cytes (2.43 ± 1.96) was significantly higher than that of
control cells (P = 0.026), and further increased upon ex-
posure to DEB (3.69 ± 1.68). In control cells, the inci-
dence of spontaneously occurring T-SCEs was minimal
(0.32 ± 0.06) and almost unchanged in response to DEB
(Figure 3f ).
Effects of ionizing radiation on apoptosis of FANCD2
leucocytes and fibroblasts
As shown in Figure 3g and Figure 3h both FANCD2 leu-
cocytes and fibroblasts appeared to die spontaneously at
higher rate than control. Upon irradiation the percent-
age of leucocytes underwent apoptosis was 2.59-fold
higher than that in control (P = 0.0001), while in fibro-
blasts, the mild 2-h delay of entering apoptosis was
observed. Both FANCD2 and control fibroblasts exten-
sively enter apoptosis 24 h after irradiation.
Effects of diepoxybutane and ionizing radiation
on percentage of telomere dysfunction-induced foci
in FANCD2 fibroblasts
Representative images of FANCD2 nuclei hybridized with
telomeric PNA probes using TIF protocol are presented in
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Figure 1 FANCD2 immunoblotting of fibroblast extracts from FA-D2 patients and control cell lines. Exposure of the 1823, 1866 (2 cell lines
from the same patient) and 1879 patient cell lines to 50nM MMC for 24 h and subsequent analysis by Western blot (loading control Vinculin, L: lane for
the Ladder). A Assignment to group FA-D2 of 18663 and 18665 patient cell lines on the basis of the absence FANCD2 on Western blot. B Assignment
to group FA-D2 of 1823 and 1879 patient cell lines on the basis of the absence FANCD2 band on Western blot. C Over-exposure of immunoblots
reveals that 1823, 18663, 18665 and 1879 patient cell lines show faint but visible FANCD2 bands in response to MMC.
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Figure 2 Representative images of metaphase spreads hybridized with telomeric PNA probes using Q-FISH (panels a-d) and CO-FISH
(panels e-h) protocols. (b-d) Aberrant telomeric structures (blue arrows indicate long strings of fragmented telomeric signals: indicative of
fragile telomeres) (e-h) The majority of chromosomes within a metaphase spread showed characteristic CO-FISH hybridization patterns in which
telomere signals at opposite ends of the chromosome were in the trans position with respect to the sister chromatids. (a,e and f) Chromatid
breakages in metaphase events of FANCD2 cells (arrows indicate no telomeric signals on the breakage points). (g-h) Telomere sister chromatid
exchanges (red arrows).
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Figure 3 (See legend on next page.)
Joksic et al. Genome Integrity 2012, 3:6 Page 4 of 12
http://www.genomeintegrity.com/content/3/1/6
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Figure 3 Results of analyses in FANCD2 and control lymphocytes. a Average telomere length (arbitrary units of RTLU ± SD) measured by Q-
FISH in FANCD2 (1823, 1866, 1879 and 2093) and control (C1-C4) cells. Cells originated from FANCD2 patients display shorter telomeres than the
age-matched controls (p = 0.024). b The distribution of telomere length indicated that control lymphocytes displayed typical Poisson distributions
for individual chromosome telomere length, whereas the peak of Poisson distribution was shifted leftward in FANCD2 lymphocytes. c The
percentage of fragile and long extended telomeres: in FANCD2 lymphocytes the percentage of cells displaying fragile telomeres is 18.45% on the
average, wheras percentage of cells displaying long-extended telomeres is 17.83%. d SCE analysis. The incidence of spontaneous SCE in FANCD2
lymphocytes was significantly reduced when compared to control (p < 0.05). In response to DEB, almost two-fold increase of SCEs was observed
in FANCD2 lymphocytes relative to the baseline state before treatment (p = 0.04). Metaphase spread showing DEB treated FANCD2 lymphocytes
with 13 SCE and two chromosomes with dSCE . f CO-FISH analysis. The incidence of spontaneously occurring T-SCEs in FANCD2 lymphocytes
was significantly higher than that in control cells (p = 0.026), and further increased in response to DEB. g Apoptosis assay showed a significant
difference between FANCD2 and control leucocytes in percentage of spontaneously dying cells as well as in percentage of apoptotic cells
induced by ionizing radiation. The data are presented as mean ± SD. h Apotosis of FANCD2 and control fibroblasts: FANCD2 cells spontaneously
die with higher rate than controls and exhibit a mild delay in entering apoptosis. The data are presented as mean ± SD.
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FANCD2 and control fibroblasts are presented in Figure 5.
While γ-H2AX foci were present in both control (5%) and
FANCD2 fibroblasts (13.27%) enhanced co-localisation of
the γ-H2AX with telomeres was observed only in
FANCD2 fibroblasts. As shown in Figure 5a, in average
51.7% of γ-H2AX foci positive cells were TIF-positive
(displaying more than five TIFs per nucleus). It is worth
noting that the level of spontaneously occurring TIFs in-
versely correlated with telomere length (P= 0.03), which
emphasizes that shortened telomeres are the underlying
cause of their dysfunction.
After DEB treatment, the percentage of TIF-positive
FANCD2 cells was significantly reduced (P=0.026)a b
e f
i j
Figure 4 Representative images of cell nuclei with or without telome
examples of FANCD2 nuclei with TIFs. (a, e) DAPI (b, f) γ-H2AX, (c, g) Telom
a yellow pattern is seen, indicating co-localisation of γ-H2AX with telomere
TIFs), (i) DAPI, (j) γ-H2AX, (k) Telomeres and (l) Merged. Zeiss-Axioimager A
acquisition software (Imaging Associate) and software package from MetaScompared to self-state before treatment, whereas in control
fibroblasts the percentage of TIF-positive cells slightly
increased (Figure 5a).
Upon irradiation, the total number of γ-H2AX foci in
FANCD2 fibroblasts was significantly higher at all recov-
ery times, relative to control samples (Figure 5b). Distri-
bution of radiation-induced foci among cells with a
recovery time of 30 min, revealed a 2-fold increase in
the number of cells containing more than 30 foci per
cell; significantly higher compared to that in control
fibroblasts (P < 0.05) (Figure 5b). Unexpected, at the
same recovery time (30 min) when the incidence of γ-
H2AX foci was maximal significant decrease of TIFs was
observed (Figure 5c). Afterwards, the percentage of TIFc d
g h
k l
re dysfunction-induced foci (panels a-l). (a-h) Representative
eres and (d, h) Merged. When green and red signals overlap (merge)
s (i-l) Control cell nuclei with distinct γ-H2AX and telomere signals (no
1 microscope equipped with a CCD camera, Axiocam image
ystem were used for analysis.
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Figure 5 Results of analyses in FANCD2 and control fibroblasts. a Average incidence of radiation- induced γ-H2AX foci per cell (mean ± SD)
in FANCD2 (n = 4) and control fibroblasts (n = 6). The total number of γ-H2AX foci in FANCD2 fibroblasts was significantly higher at all recovery
times, relative to control samples. b Percentage of FANCD2 cells displaying more than 30 γ-H2AX foci per cell within recovery time of 30 min,
revealed a 2-fold increase compared to that in control fibroblasts (p < 0.05). c TIF analysis. In FANCD2 fibroblasts, in average 51.7% of nuclei were
TIF-positive (displaying more than 5 TIFs per nucleus). The level of TIFs inversely correlates with telomere length (P = 0.03). Percentage of TIF
positive cells significantly decreased after irradiation. At recovery time of 30 min considerable percentage of TIF positive cells disappeared at the
same time when the incidence of γ-H2AX foci was maximal. Afterwards, TIFs appeared again, but in less extent and remained almost the same at
all later recovery times. 24 h after DEB treatment, the percentage of TIF-positive FANCD2 cells also was reduced (p = 0.026) when compared to a
self-state before treatment.
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same over the next 2, 5 and 24 h. Percentages of dying
FANCD2 fibroblasts were almost the same prior and 2 h
after irradiation (Figure 5d) indicating that cell loss is
not the reason for TIFs disappearance. The observations
that FANCD2 cells exhibit a mild 2-h delay in entry into
apoptosis after irradiation and a 2-fold higher rate of
spontaneous apoptosis relative to control signify difficul-
ties in activation of physiological mechanisms of cell
death that happened exactly at the time when treated
cells did not display TIFs.
Relative expression of TRF1 and TRF2 mRNAs
Relative to control cells, the relative expression of TRF1
mRNA in FANCD2 fibroblasts was significantly down-
regulated by a mean factor of 0.31 (S.E. range 0.093 –
0.610, 95%CI 0.088-0.697, P = 0.000) (Figure 6). TRF2gene expression was similar in both FANCD2 and con-
trol cells (mean factor 1.178, S.E. range 0.814 - 1.71, 95%
CI 0.771 - 1.801, P = 0.7). The TRF1:TRF2 ratio was
close to 1 (P = 0.7) in control cells. We did not detect
significant differences in TRF1 or TRF2 gene expression
between FANCD2 and control cells following irradiation
or treatment with DEB.
Discussion
This study provides evidence that primary cells originat-
ing from FA-D2 patients display shorter telomeres than
their age-matched control counterparts, high frequency
of dysfunctional telomeres, and broad spectrum of aber-
rant telomeric structures ranging from fragile to long-
string extended telomeres. Furthermore, telomeres in
FANCD2 primary cells display extra heterogeneous telo-
mere lengths of individual chromosomes and elevated
*Figure 6 The relative expression of shelterin compounds TRF1
and TRF2 mRNA in FANCD2 (n= 4) and control fibroblasts
(n = 6). The relative level of TRF1 and TRF2 mRNA was standardized
against the housekeeping gene 18 s rRNA and calculated using
relative expression software tool, REST 09. The squares represent
relative expression of TFR1 and TRF2 in FANCD2 cells versus control
cells. The box area in a whisker-box plot encompasses 50% of all
observations, the dotted line represents the sample median and the
whiskers represent the outer 50% of observations.
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Callen et al. [14] and Leteurtre et al. [20] have demon-
strated the presence of shorter telomeres in FA patients
(mostly belonging to the complementation group FA-A)
than their age-matched controls, which is consistent
with our findings in FA-D2 patients. Herman et al. [21]
proposed that average telomere length is not the only
determinant of telomere function, emphasizing that crit-
ically short individual telomeres can trigger cellular
responses to a loss of telomere function. The heterogen-
eity of telomere length that was present in our FA-D2
patients was expressed as SD of telomere length; our
correlative analysis supports their hypothesis that critic-
ally short telomeres trigger a DDR response that reduces
telomere capping function. Metaphase events presented
in Figure 2(b-d), illustrate a hybridization pattern with
aberrant telomeric structures ranging from fragmented
telomeric signals to an extended strand of telomeric
DNA; these patterns are indicative of telomere dysfunc-
tion. The findings of this study support those reported
in several prior studies [22-26] with embryonic stem
cells lacking TRF1. In this study, all FA-D2 patients
exhibited decreased TRF1 expression, which correlates
to telomere defects. Because TRF1 has been described as
a negative regulator of telomere length [27], reduced
TRF1 expression is thought to induce telomere elong-
ation; however, this did not occur. In contrast to tumor
cells [28,29], down-regulation of TRF1 in FANCD2 cells
is probably linked to the functional role of TFR1 inregulating cell cycle progression. In response to DNA
damage, ATM beside histone H2AX, phosphorylates
TRF1 to inhibit its mitotic function and prevent abortive
mitosis. Given that FANCD2 cells exhibit a 2-fold increase
in the number of cells displaying more than 30 γH2AX-
foci per cell after irradiation, down-regulation of TRF1
may be a consequence of its degradation due to the failure
of cells to progress into the cell cycle normally, as is the
case with control cells. Down-regulation of TRF1 may also
provide cells to increase their proliferative potential.
By employing the CO-FISH technique, our study
demonstrates a two-fold enhancement of T-SCEs in
FANCD2 cells, relative to control cells. This may result
from an attempt to replenish lost telomeric sequences by
homologous recombination between sister telomeres.
While there is currently no direct evidence that T-SCEs
modify telomere length, the recombinogenic behavior of
telomeres in FANCD2-deficient cells could contribute to
heterogeneity in telomere length, which in turn activates
DDR. Recent work by Lyakhovich et al. [30] with immor-
talized FANCD2 fibroblasts has shown that extrachromo-
somal circular telomeric structures in FANCD2-deficient
cells are not linked to telomeric recombination between
sister chromatids. In our study, FISH analysis of primary
FANCD2 cells did not reveal extrachromosomal telomeric
signals; in contrast, fragile telomeres and split or extended
telomeric signals were frequently observed. Recent work
of Polanska et al. [31], have shown that chromatin asso-
ciated protein (HMGB1) also maintain telomere inte-
grity. The most interesting finding in their study is that
HMGB1−/− cells exhibit heterogeneous telomere lengths
of individual chromosomes and highly extended telo-
meres, as we found in lymphocytes of our FANCD2
patients.
Considering the role of TRF2 in telomere mainten-
ance, many studies with mouse models have revealed
that T-SCE are repressed by TRF2 [32]. Expression of
TRF2 in either FA cells or control cells was nearly iden-
tical, indicating that an increase of T-SCE could be
attributed to some other proteins; examples of which in-
clude those that regulate histone heterochromatin dens-
ity in telomeric and sub-telomeric regions and influence
chromatin remodeling, as suggested by Schoeftner and
Blasco [33], and Polanska et al. [31].
The novel finding of our study is that a remarkably high
percentage of FANCD2 cells had dysfunctional telomeres
that were mostly caused by telomere shortening collect-
ively with extensive telomere length heterogeneity of indi-
vidual chromosomes (i.e., 1866 cells displayed 74% of TIF
positive cells). Although elevated incidence of γH2AX foci
in FANCD2 cells vs. control was observed at all recovery
times after irradiation, a significant decrease of TIFs was
determined at the same post-irradiation times. Particularly
unexpected was a considerable disappearance of TIF
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of γH2AX foci was maximal (Figure 5a). Afterwards, TIFs
appeared again, but in less extent and remained almost the
same at all later recovery times. When we look at the apop-
tosis profile of FANCD2, it is evident that percentage of
dying cells was almost the same up to 2 h after irradiation
(compared to a baseline state), indicating that cell loss is
not the reason for TIFs disappearance. The work of Kaul
et al. [34] have shown that normal human cells can tolerate
small number of TIFs, so called “intermediate-state” telo-
meres. We hypothesize that repair-deficient FANCD2 cells
could possibly tolerate bigger number of intermediate-state
telomeres. However, upon irradiation FANCD2 cells display
fast and marked reduction of TIFs, which is likely due to a
recruitment of γH2AX away from telomeres to newly
formed DSBs. Irradiated FANCD2 fibroblasts exhibit mild
delay of 2 h in ingoing apoptosis relative to control, signify-
ing difficulties in activation of physiological mechanisms of
cell death. Accelerated telomere shortening in radiosensi-
tive cell lines has been reported in several prior publica-
tions [35,36]. Collectively, the data presented by our study
suggests that uncapping of telomeres results from an
increase in telomere recombination, in addition to acceler-
ated telomere shortening; this is consistent with general
enhancements in the activity of HR. For example, 1823 cells
possess telomeres of nearly normal length and display no
increase in HR activity; therefore, we conclude that only
cells with sufficiently long telomeres bypass HR to rep-
lenish telomeric repeats. In FANCA cells, telomere
dysfunction-induced foci were found in less than 10% of
cells. FANCA also exhibit shorter telomeres than controls,
but in contrast to FANCD2 exhibit fast progression, no
delay in cell cycle and display very few TIFs in base-line
state, and in response to irradiation behave in a similar
manner as controls (unpublished data).
In response to cross-linking agents, FANCD2 lympho-
cytes exhibited a 2-fold increase in the frequency of SCE
when compared to control cells. In control lymphocytes,
progression of SCE in response to DEB was suppressed.
To the best of our knowledge, this is the first report that
describes a role of the cross-linking agent DEB in suppres-
sing the occurrence of SCE in normal cells and signifi-
cantly enhancing it in FA cells. Particularly frequent
double SCE were observed, as illustrated in Figure 3f.
Increased SCE incidence upon DEB treatment suggests
that replication fork collapse may occur because of the in-
ability of cells to repair replication-blocking lesions and
initiation of homologous recombination. According to
findings in our study incidence of SCE induced by DEB
can be used as an adjunct diagnostic test for FA cellular
phenotype. High-rates of homologous recombination in
human FA cells first were observed by Thyagarajan and
Campbell [37], who discovered that recombination levels
in Fanconi anemia cells were nearly 100-fold higher than incontrol cells. The authors proposed that inappropriate in-
crease in the amount of homologous recombination might
contribute to genomic instability and cancer susceptibility
that characterized FA. Rouet et al. [38] found that HR pro-
cesses operate on DSBs, which can further rationalize our
finding that enhanced HR activity was present in treated
FA-D2 cells [38]. Work of Yamamoto et al. [39] have shown
that sensitivity of FANCD2 cells to cross-linking agents
and ionizing radiation is mainly due to premature termin-
ation of repair during DNA synthesis. Nakanishi and col-
leagues [40] provide evidence that cells derived from
FANCA, FANCG and FANCD2 patients are defective, to a
mild degree in HR. Smogorzewska et al. [41] verify that
siRNA mediated depletion of FANCI and FANCD2
resulted in reduced HR activities. Indeed, the results of our
study revealed reduced rate of SCE in FANCD2 cells and
higher rate of spontaneously dying cells versus control,
which is in accordance to previously mentioned findings.
The mechanism by which telomere dysfunction is
initiated remains unresolved. Broccoli et al. [42] postulated
that dysfunctional telomeres may fall below a threshold of
telomere-associated proteins, such as TRF1 and TRF2,
thereby impairing the formation of the telomere loop
structure; however, subsequent studies, including our
study, determined that this effect is not connected to these
important shelterin components. Morish and Greider [43]
reported that mammalian cells utilize several different
non-telomerase mechanisms for telomere maintenance,
which include recombination initiated by short telomeres;
the results of our study support this hypothesis. The work
of Fan and colleagues [44] have shown that depletion of
FANCD2 is associated with decrease in recombination
between telomeres. In our study the opposite results were
obtained, which can be explained in part by the fact that
truncated FANCD2 protein in primary FA-D2 cells is still
competent to function in HR. Telomere findings in our
study confirm that FANCD2 cells maintain telomeres
trough homologous recombination displaying a more het-
erogeneous length and increased chromosomal instability
including TIFs. Interestingly no fusions were observed in
either lymphocytes or fibroblasts indicating that telomeres
are not critically shorten to be fused. This observation is
in line with work of Cesare and colleagues who postulated
that not all uncapped telomeres are equal, pointing out
that some cells as cancerous cells posses TIF positive telo-
meres that are not involved in fusions [45]. The similar
distinctiveness of telomeres in primary cells originated
from FA-D2 patients are observed in our study.
Taken together, our study revealed that high percent-
age of TIFs that characterized FANCD2 primary cells is
most likely induced by critically shortened telomeres. In
addition, fragile and long-string extended telomeres
along with disappearance of TIFs in early response to
irradiation are distinctive features of FANCD2 primary
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function is a plausible explanation for the increased can-
cer susceptibility and clinical hypersensitivity of all FA
patients, not only of the FA-A complementation group.
Methods
Patients
The patients included in this study were four female
children with Fanconi anemia belonging to complemen-
tation group FA-D2. The patients were 8 ± 5 years of
age. Cellular FA phenotype was diagnosed with classic
chromosomal breakage DEB tests of peripheral blood
lymphocytes, as described by Auerbach et al. [46].
Patients who displayed DEB-positive lymphocyte
phenotypes underwent skin biopsies to assess FA fibro-
blast phenotype and to determine genetic subtype.
Healthy age-matched volunteers served as control
groups (12 subjects as controls for SCE analysis, and 4
subjects as controls for telomere length analysis). All
methods were approved by the Ethical Committee of the
Mother and Child Health Care Institute of Serbia, and
the subjects’ parents signed informed consent forms.
Cell culture
Lymphocytes
Peripheral blood was collected from all subjects and
deposited into heparinized vacutainer tubes. Lympho-
cytes were cultured in PBmax karyotyping medium
(Invitrogen-Gibco, Paisley, UK). Adequate numbers of
cell cultures per subject were established, enabling SCE
analysis, T-SCE analysis and telomere length analysis via
quantitative FISH (Q-FISH) in metaphase cells.
Fibroblasts
Cells were grown in DMEM (Invitrogen-Gibco, Paisley,
UK) supplemented with 10% fetal bovine serum (Invitro-
gen-Gibco, Paisley, UK) under standard tissue culture con-
ditions: 37°C in 10% CO2. Cells were harvested in duplicate
and propagated to 80-90% confluence, at which point cells
were subcultured. A 1.0 mL cell suspension was prepared
at a density of 50,000 cells for each sample, and the cells
were seeded onto polylysine-coated glass slides (Sigma
Chemical Co., St Louis, MO) and incubated overnight in
atmosphere-controlled chamber containing 10% CO2. As a
control, primary cells from skin biopsies of six healthy sub-
jects undergoing plastic surgery were also used.
Irradiation
Irradiation was performed with a 60Co γ-ray source
(a 2.0 Gy dose at 0.45 Gy/min). Fibroblasts were irra-
diated on polyprep slides and then returned to the tissue
culture incubator and examined at various recovery
times (30 min, 2 h, 5 h and 24 h).Diepoxybutane treatment
Cells were treated with DEB at final concentration of
0.1 μg/mL or 0.01 μg/mL for lymphocytes and fibro-
blasts, respectively. Fibroblasts were exposed to DEB for
24 h, whereas lymphocytes were exposed for 72 h.
Western blot analysis for the subtyping of FA patients
Exposure of the patients and controls cell lines to 50nM
mitomycin C (MMC) for 24 h and subsequently analysis
by FANCD2 western blot was performed as previously
described by Casado et al. [47] and Castella et al. [48].
Anti-FANCA antibodies (gift of the Fanconi Anemia
Research Fund, dilution 1:500) and anti-FANCD2 anti-
bodies (Santa Cruz Biotechnology, Santa Cruz, California,
USA) (dilution 1:2500) were used. Assignment of group
FA-D2 was done on the basis of the absence FANCD2 on
Western blots usingWestern Breeze Immunodetection Kit
(Invitrogen, Grand Island, NY, USA). The over-exposure of
films by the chemiluminescence technique to identify re-
sidual FANCD2 protein levels was performed as described
by Kalb et al. [19].
Quantitative fluorescence in situ hybridization
For Q-FISH, cells were harvested under standard condi-
tions. During the final 3 h of incubation, 0.1 μg/mL of col-
chicine (Sigma Chemical Co., St Louis, MO) was added to
cell cultures. Subsequently, a hypotonic solution (5.6 g/l of
KCl) was added, followed by three consecutive fixations
with 3:1 methanol/acetic acid; thereafter, slides were pre-
pared. Q-FISH was performed as described by Slijepcevic
[49]. Briefly, after appropriate wash steps, the slides were
hybridized with the Cy-3 labeled telomeric PNA probe
(CCCTAA) 3' and left in a dark humidified chamber for
2 h. The slides were then washed in 70% formamide and
stained with 4', 6’-diamidino-2-phenylindole (DAPI)-con-
taining mounting medium (Vector Laboratories, UK).
Chromosomal analysis was performed with a Ziess-
Axioplan2 microscope equipped with a CCD camera,
Axiocam image acquisition software (Imaging Associate)
and software package from MetaSystem. Measurements
were reported as arbitrary relative telomere length units
(RTLU), which are defined as the ratio of signal intensity
between telomeres and a centromere chromosome 2 refer-
ence signal.
Sister chromatid exchange analysis
Cells intended for SCE analysis were cultured in dupli-
cate and allowed to undergo two rounds of replication
in the presence of 5-bromo-2-deoxyuridine (BrdU)
(Sigma Chemical Co., St Louis, MO) to achieve differen-
tiation of sister chromatids. BrdU was added one hour
after culture initiation and cells were harvested at 72 h,
the final three hours of which were conducted in the pres-
ence of colchicine (final concentration 0.1 μg/mL). One of
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ring SCE, while a second was treated with DEB one hour
after culture initiation, and continued for as long as 72 h.
After conventional hypotonic treatment, cells were fixed
three times in 3:1 methanol: acetic acid. Afterward, the
pellet was spread onto glass microscope slides. Differential
staining of sister chromatids was performed via standard
fluorescence-plus-Giemsa (FPG) technique [50]. A total of
30 complete second-division metaphase cells were ana-
lyzed per sample with a Ziess-Axioplan2 microscope.
Chromosome orientation fluorescence in situ
hybridization
Parallel cultures were used to conduct telomere T-SCE
analysis. The chromosome orientation fluorescence in situ
hybridization (CO-FISH) protocol of Bailey et al. [51] was
performed with some modification for lymphocytes: 48 h
after the start of culture, 30 μM BrdU and 10 μM bromo-
deoxycytidine (BrdC) (Sigma Chemical Co., St Louis, MO)
were added and cells were allowed to progress through S
phase and into the first mitosis the following day. Colchi-
cine was added to a final concentration of 0.1 μg/mL dur-
ing the last 3 h of culture. Preparation of cultures was
performed according to the standard protocol (hypotonic
treatment and three consecutive fixations in 3:1 methanol:
acetic acid). Cell pellets were spread onto glass microscope
slides using cytogenetic techniques. Newly synthesized
DNA strands were degraded by treating fixed cells on
glass microscope slides with 0.5 μg/mL Hoechst 33258 for
15 min (Sigma Chemical Co., St Louis, MO), 313 nm light
for 30 min and 3 U/μL Exo III (Promega, Madison, WI) at
room temperature for 10 min. Slides were washed in PBS
and subsequently dehydrated in a series of ethanol washes.
Tel Cy3-dUTP (20 μL), a telomere PNA probe (Panagene,
Korea) was placed onto each slide, covered with glass cov-
erslips and hybridized on a hot plate for 5 min at 80°C.
After hybridization, slides were maintained in the dark in
a wet compartment for 2 h. Afterwards, the slides were
washed three times in 70% formamide/2xSSC for 15 min,
and then washed three times in PBS for 5 min. Samples
were then dehydrated in ice-cold ethanol, mounted in
DAPI (Vectashield), covered with coverslips and sealed. At
least 20 metaphase events from each patient were quanti-
fied by CO-FISH. Each metaphase event was analyzed
with Axiocam image acquisition software (Imaging Asso-
ciate) and a software package from MetaSystem. The data
were subsequently analyzed by quantifying descriptive sta-
tistics (mean values, SD and SE).
TIF assay
For the TIF assay, cells were co-stained with γH2AX and
telomere in situ hybridization using a telomere-specific
peptide nucleic acid probe. Polylysine-coated slides on
which cells were grown were rinsed in PBS and fixed in4% formaldehyde for 15 min. Cells were permeabilized in
0.2% (v/v) Triton-X in distilled water at 4.0°C for 10 min
and blocked with 0.5% (w/v) bovine serum albumin (BSA)
in PBS for 30 min. Anti-phospho- histone H2AX (Ser139)
(Millipore, USA) was diluted 1:500 with 0.5% BSA; 100 μL
of the resulting solution was added to each slide and incu-
bated for 1 h in a humidified container. After three washes
in sterile tris-buffered saline containing tween-20 (TBS-T,
pH7.4; 0.15 M NaCl, 0.268 mM KCl, 0.025 M tris-base,
500 μL/1 l tween-20) for 3 min, slides were incubated with
100 μL of anti-goat secondary antibody conjugated to
fluorescein isothiocyanate (FITC) and washed as described
above. The slides were then placed in 4% formaldehyde
for 20 min to facilitate cross-fixing and antibody preserva-
tion. The following step involved hybridization to a telo-
meric PNA probe, which was performed as described
above with the exception that TBS-T was used for wash-
ing instead of PBS. A large number of cells (100) were
analyzed for each sample. TIFs were measured before
irradiation (baseline state) and at different times after
exposure to ionizing radiation (30 min, 2 h, 5 h and 24 h)
and 24 h after DEB treatment.
Apoptosis assay
Blood cells: For apoptosis assay, aliquots of 0.5 ml periph-
eral blood from each subject were cultured in duplicate.
One of these cultures was used for analysis of spontaneous
apoptosis, while the second culture was set up by using the
irradiated whole blood. Blood cells were incubated in
medium RPMI-1640 supplemented with 15% of calf serum
without phytohemaglutinin (PHA) in CO2 incubator for
24 h. After incubation, cells were gently washed with
physiological saline (0.9% NaCl) at 37°C, fixed in methanol:
acetic acid (3:1) and subsequently fixed in 96% ethanol.
Fibroblasts: At each time point after irradiation and/or
DEB treatment cells were detached from the flasks sur-
face with 0.025 M trypsin-EDTA (Gibco, Invitrogen Ltd.,
Paisley, UK), washed with pre-warmed PBS (Bioatlas,
Tartu, Estonia) at 37°C and fixed in 96% ethanol. Apop-
tosis was assessed by flow cytometric (Becton Dickinson,
Heidelberg, Germany) identification of cells displaying
apoptosis associated DNA condensation. DNA content
was assessed by measuring the UV fluorescence of pro-
pidium iodide-stained DNA. Apoptotic population ana-
lysis was performed using CellQuest software (Becton
Dickinson, Franklin Lakes, NJ, USA).
Isolation of RNA and quantitative real-time reverse
transcriptase-PCR
Total RNA was isolated from each cell culture flask
(both untreated fibroblasts and those treated with DEB or
radiation) using the TRI reagent (Ambion, Inc.) in accord-
ance with the manufacturer’s instructions. The quantity
purified mRNA was assessed with a NanoDropW ND-1000
Joksic et al. Genome Integrity 2012, 3:6 Page 11 of 12
http://www.genomeintegrity.com/content/3/1/6spectrophotometer (Thermo Scientific, Wilmington, Dela-
ware). Structural RNA integrity was confirmed by formal-
dehyde gel electrophoresis. One microgram of RNA was
treated with DNAse I (Fermentas, Lithuania) and reverse
transcription was performed using a first strand cDNA syn-
thesis kit with oligo-dT18 primers (Fermentas, Lithuania)
according to the manufacturer’s instructions. Mock reac-
tions lacking reverse transcriptase (RT) were performed
during the cDNA synthesis step to exclude genomic con-
tamination. Real-time PCR was performed in duplicate in
an ABI Real-time 7500 system (ABI, Foster City, CA). De-
tection of TRF-1 and TRF-2 gene expression was accom-
plished with 0.2 μmol/L of each primer and 0.1 μmol/L of
probe in TaqManW gene expression master mix in a total
volume of 25 μL. The sequences of the primers and probes
are as follows: TRF1, forward primer 5’-CCACATGATGG
AGAAAATTAAGAGTTAT-3’, reverse primer 5’-TGCC
GCTGCCTTCA TTAGA-3’, probe 5’-FAM-TTATGTG
CTAAGTGAAAAATCATCAACCT-TAMRA-3’ [52]. The
results from the RT-PCR assays were validated by amplify-
ing the serial dilutions of a sample by 10-fold, and the
slopes of amplification curves were calculated. Detection of
internal reference 18 s rRNA was performed with pre-
developed TaqManW Gene Expression Assays ID
Hs99999901_s1 (ABI, Foster City, CA), although the
glyceraldehyde-3- phosphate dehydrogenase (GAPDH,
Hs99999905_m1) and cyclophilin A (CYCA, Hs999999
04_m1) were run on all the samples as two additional en-
dogenous controls. Differences in mRNA expression,
according to genotypes of the investigated polymorphisms,
were tested with REST 09 software (Corbett Life Science,
http://rest.gene-quantification.info) [53].
Statistics
The data were analyzed using statistical software pack-
age 7.0. Statistical analyses were performed via Student’s
t test. Correlations between investigated parameters
were tested with linear regression analysis. A P value less
than 0.05 was considered statistically significant. Differ-
ences in mRNA expression between groups were tested
by pairwise randomization and boot strapping with the
relative expression software tool, REST 09 (Corbett Life
Science) [53].
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